跳至主要内容
临床试验/CTRI/2021/05/033464
CTRI/2021/05/033464招募中未知

Thromboelastography guided vs. On-demand blood product transfusion in patients with cirrhosis undergoing high-risk invasive procedures: A Randomized Controlled Trial.

Dr Shalimar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. cirrhosis patients (age: 18-65 years) with platelet count ( <50,000/mm3) irrespective on INR values undergoing elective high-risk procedures.

排除标准

  • 1.Patients with malignancy (except hepatocellular cancer) /disseminated intravascular coagulation (DIC)/known coagulopathy (hemophilia),
  • 2.Patients on platelets inhibitors or vitamin K antagonists within past 7 days,
  • 3.Active oral contraceptive use
  • 4.Pregnancy
  • 5.Underlying hypercoagulable/ hypocoagulable states eg. paroxysmal nocturnal hemoglobinuria (PNH), polycythemia vera, etc,
  • 6.Those who received blood products (fresh frozen plasma and/or platelet prior to thromboelastography)
  • 7.Patients with shock (BP <90/60 mmHg), and
  • 8.Any infection/Sepsis.
  • 9.Acute-on chronic liver failure
  • 10.Acute Kidney Injury
  • 11.Chronic Kidney Disease

研究者

发起方
Dr Shalimar

相似试验